Zevra Therapeutics Cash Flow Statement (2014-2026) | ZVRA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-1.76M-2.70M10.49M-21.97M-5.70M-2.97M-13.22M-2.57M-10.37M-19.89M-16.62M-19.93M-33.23M-35.74M-3.10M74.71M-0.54M12.16M37.89M8.75M
Share-based Compensation (Quarter)
0.62M-1.61M0.92M1.51M0.91M0.59M1.10M1.39M1.47M2.12M2.63M6.14M4.02M3.12M2.46M2.77M4.28M2.63M2.97M
Gains from Investment Securities (Quarter)
-0.33M-0.07M-0.24M-0.03M-0.02M-0.03M0.00M
Asset Writedowns and Impairment (Quarter)
0.46M11.70M-0.02M0.48M
Cash from Operations (Quarter)
-2.73M-0.85M-3.55M-4.10M-6.60M-4.46M-4.04M-8.70M-4.63M-16.16M-16.16M-19.11M-18.14M-16.25M-8.22M-3.60M4.71M5.52M6.14M17.03M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.89M0.30M0.76M1.21M0.86M0.62M0.59M
Amortization of Deferred Charges (Quarter)
0.12M0.12M
Depreciation & Amortization (CF) (Quarter)
0.07M0.06M0.07M0.18M0.40M0.30M0.08M0.08M0.06M0.79M1.56M1.56M1.62M1.65M1.65M1.65M0.39M0.36M0.37M0.32M
Change in Working Capital
Change in Receivables (Quarter)
-0.27M-0.09M1.79M-0.50M3.35M2.13M-0.48M6.21M-4.11M7.45M-9.07M0.64M-1.16M2.72M2.11M4.86M-1.36M6.37M-6.89M5.74M
Change in Inventory (Quarter)
-0.04M-0.24M0.13M-0.05M-0.07M-0.07M-0.02M2.58M0.99M0.58M4.71M0.20M0.38M0.19M0.53M0.18M0.14M
Change in Account Payables (Quarter)
-4.39M-0.50M
Change in Accured Expenses (Quarter)
-0.19M0.78M-0.49M1.12M0.63M1.87M3.84M-0.89M2.45M5.73M-7.31M-1.30M-1.99M6.99M-7.26M-4.00M-4.73M0.41M-0.53M2.32M
Other Working Capital Changes (Quarter)
0.04M-0.54M-0.30M2.19M-0.70M-0.30M-0.70M1.04M-0.36M-0.12M0.04M0.82M-0.41M1.78M-0.29M0.58M3.05M-0.40M0.09M-0.15M
Investing Activities
Capital Expenditures (Quarter)
0.06M0.02M-10.49M10.52M0.03M-0.45M0.03M0.02M0.17M0.07M0.10M0.21M0.55M-0.03M0.04M0.22M
Sales of Property, Plant and Equipment (Quarter)
-0.14M0.04M
Change in Intangibles (Quarter)
43.94M5.00M
Acquisitions (Quarter)
14.08M30.40M
Change in Acquisitions & Divestments (Quarter)
0.30M9.50M15.62M14.79M10.01M0.20M18.00M12.50M60.50M87.50M93.97M49.25M
Cash from Investing Activities (Quarter)
-0.00M-15.44M-3.85M-33.08M0.27M-0.06M-17.55M34.04M-44.46M10.59M14.79M-0.13M-31.35M-5.47M10.54M11.93M-4.58M0.23M79.62M31.45M
Financing Activities
Other financing activities (Quarter)
10.70M10.70M0.22M0.11M0.05M-0.00M1.15M0.16M-1.30M2.95M0.57M5.12M9.17M
Cash from Financing Activities (Quarter)
1.94M-2.87M-4.73M13.75M-0.34M-0.33M-3.75M0.95M26.26M5.00M1.22M15.33M64.77M0.80M1.61M1.38M6.53M2.55M-52.80M1.58M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
6.11M1.22M-0.07M63.37M
Additional items
Exchange Rate Effect (Quarter)
0.01M0.19M0.07M-0.27M-0.10M0.35M-0.04M0.32M-0.49M0.67M-0.37M0.66M0.06M-0.32M0.23M-0.34M
Change in Cash (Quarter)
-0.79M-19.16M-12.13M-23.43M-6.65M-4.66M-25.29M26.02M-22.93M-0.22M-0.20M-3.59M14.78M-20.25M3.56M10.37M6.73M7.97M33.19M49.73M
Free Cash Flow (Quarter)
-2.79M-0.86M6.93M-14.62M-6.63M-4.02M-4.07M-8.73M-4.80M-16.23M-16.16M-19.11M-18.14M-16.25M-8.32M-3.81M4.16M5.55M6.11M16.82M
Net Cash Flow (Quarter)
-0.79M-19.16M-12.13M-23.43M-6.67M-4.85M-25.35M26.28M-22.82M-0.57M-0.15M-3.91M15.27M-20.93M3.93M9.71M6.66M8.29M32.96M50.07M